The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Non-Radioactive Nucleic Acid Labeling Product Market Research Report 2024
Synopsis
In recent years, non-radioactive nucleic acid labeling and detection methodologies have become available in response to a desire by researchers and their institutions to move away from the use of radioisotopes. Advancements made in the areas of chemiluminescence and fluorescence have allowed for an easier transition. In non-radioactive assays, signal is generated through an enzymatic reaction with a chemiluminescent or chromogenic substrate; alternatively, detection can occur through the appropriate excitation and emission of a fluorophore-labeled probe.
The global Non-Radioactive Nucleic Acid Labeling Product market was valued at US$ 342 million in 2023 and is anticipated to reach US$ 548.6 million by 2030, witnessing a CAGR of 6.9% during the forecast period 2024-2030.
Global Non-Radioactive Nucleic Acid Labeling Product key players include Thermo Fisher Scientific, Roche, Promega, etc. Global top three manufacturers hold a share over 40%.
United States is the largest market, with a share over 40%, followed by China
and Europe, both have a share about 35 percent.
In terms of product, DIG System is the largest segment, with a share about 33%. And in terms of application, the largest application is DNA Labeling, followed by RNA Labeling, Oligonucleotide Labeling.
This report aims to provide a comprehensive presentation of the global market for Non-Radioactive Nucleic Acid Labeling Product, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Non-Radioactive Nucleic Acid Labeling Product.
Report Scope
The Non-Radioactive Nucleic Acid Labeling Product market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Non-Radioactive Nucleic Acid Labeling Product market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Non-Radioactive Nucleic Acid Labeling Product manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher Scientific
Roche
Promega
PerkinElmer
Agilent Technologies
General Electric
Enzo Biochem
Merck KGaA
Vector Labs
New England Biolabs
Segment by Type
Biotin
DIG System
Fluorescent
Others
Segment by Application
DNA Labeling
RNA Labeling
Oligonucleotide Labeling
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Non-Radioactive Nucleic Acid Labeling Product manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Non-Radioactive Nucleic Acid Labeling Product in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
In recent years, non-radioactive nucleic acid labeling and detection methodologies have become available in response to a desire by researchers and their institutions to move away from the use of radioisotopes. Advancements made in the areas of chemiluminescence and fluorescence have allowed for an easier transition. In non-radioactive assays, signal is generated through an enzymatic reaction with a chemiluminescent or chromogenic substrate; alternatively, detection can occur through the appropriate excitation and emission of a fluorophore-labeled probe.
The global Non-Radioactive Nucleic Acid Labeling Product market was valued at US$ 342 million in 2023 and is anticipated to reach US$ 548.6 million by 2030, witnessing a CAGR of 6.9% during the forecast period 2024-2030.
Global Non-Radioactive Nucleic Acid Labeling Product key players include Thermo Fisher Scientific, Roche, Promega, etc. Global top three manufacturers hold a share over 40%.
United States is the largest market, with a share over 40%, followed by China
and Europe, both have a share about 35 percent.
In terms of product, DIG System is the largest segment, with a share about 33%. And in terms of application, the largest application is DNA Labeling, followed by RNA Labeling, Oligonucleotide Labeling.
This report aims to provide a comprehensive presentation of the global market for Non-Radioactive Nucleic Acid Labeling Product, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Non-Radioactive Nucleic Acid Labeling Product.
Report Scope
The Non-Radioactive Nucleic Acid Labeling Product market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Non-Radioactive Nucleic Acid Labeling Product market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Non-Radioactive Nucleic Acid Labeling Product manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher Scientific
Roche
Promega
PerkinElmer
Agilent Technologies
General Electric
Enzo Biochem
Merck KGaA
Vector Labs
New England Biolabs
Segment by Type
Biotin
DIG System
Fluorescent
Others
Segment by Application
DNA Labeling
RNA Labeling
Oligonucleotide Labeling
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Non-Radioactive Nucleic Acid Labeling Product manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Non-Radioactive Nucleic Acid Labeling Product in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Non-Radioactive Nucleic Acid Labeling Product Market Overview
1.1 Product Overview and Scope of Non-Radioactive Nucleic Acid Labeling Product
1.2 Non-Radioactive Nucleic Acid Labeling Product Segment by Type
1.2.1 Global Non-Radioactive Nucleic Acid Labeling Product Market Value Comparison by Type (2024-2030)
1.2.2 Biotin
1.2.3 DIG System
1.2.4 Fluorescent
1.2.5 Others
1.3 Non-Radioactive Nucleic Acid Labeling Product Segment by Application
1.3.1 Global Non-Radioactive Nucleic Acid Labeling Product Market Value by Application: (2024-2030)
1.3.2 DNA Labeling
1.3.3 RNA Labeling
1.3.4 Oligonucleotide Labeling
1.4 Global Non-Radioactive Nucleic Acid Labeling Product Market Size Estimates and Forecasts
1.4.1 Global Non-Radioactive Nucleic Acid Labeling Product Revenue 2019-2030
1.4.2 Global Non-Radioactive Nucleic Acid Labeling Product Sales 2019-2030
1.4.3 Global Non-Radioactive Nucleic Acid Labeling Product Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Non-Radioactive Nucleic Acid Labeling Product Market Competition by Manufacturers
2.1 Global Non-Radioactive Nucleic Acid Labeling Product Sales Market Share by Manufacturers (2019-2024)
2.2 Global Non-Radioactive Nucleic Acid Labeling Product Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Non-Radioactive Nucleic Acid Labeling Product Average Price by Manufacturers (2019-2024)
2.4 Global Non-Radioactive Nucleic Acid Labeling Product Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Non-Radioactive Nucleic Acid Labeling Product, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Non-Radioactive Nucleic Acid Labeling Product, Product Type & Application
2.7 Non-Radioactive Nucleic Acid Labeling Product Market Competitive Situation and Trends
2.7.1 Non-Radioactive Nucleic Acid Labeling Product Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Non-Radioactive Nucleic Acid Labeling Product Players Market Share by Revenue
2.7.3 Global Non-Radioactive Nucleic Acid Labeling Product Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Non-Radioactive Nucleic Acid Labeling Product Retrospective Market Scenario by Region
3.1 Global Non-Radioactive Nucleic Acid Labeling Product Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Non-Radioactive Nucleic Acid Labeling Product Global Non-Radioactive Nucleic Acid Labeling Product Sales by Region: 2019-2030
3.2.1 Global Non-Radioactive Nucleic Acid Labeling Product Sales by Region: 2019-2024
3.2.2 Global Non-Radioactive Nucleic Acid Labeling Product Sales by Region: 2025-2030
3.3 Global Non-Radioactive Nucleic Acid Labeling Product Global Non-Radioactive Nucleic Acid Labeling Product Revenue by Region: 2019-2030
3.3.1 Global Non-Radioactive Nucleic Acid Labeling Product Revenue by Region: 2019-2024
3.3.2 Global Non-Radioactive Nucleic Acid Labeling Product Revenue by Region: 2025-2030
3.4 North America Non-Radioactive Nucleic Acid Labeling Product Market Facts & Figures by Country
3.4.1 North America Non-Radioactive Nucleic Acid Labeling Product Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Non-Radioactive Nucleic Acid Labeling Product Sales by Country (2019-2030)
3.4.3 North America Non-Radioactive Nucleic Acid Labeling Product Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Non-Radioactive Nucleic Acid Labeling Product Market Facts & Figures by Country
3.5.1 Europe Non-Radioactive Nucleic Acid Labeling Product Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Non-Radioactive Nucleic Acid Labeling Product Sales by Country (2019-2030)
3.5.3 Europe Non-Radioactive Nucleic Acid Labeling Product Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Non-Radioactive Nucleic Acid Labeling Product Market Facts & Figures by Country
3.6.1 Asia Pacific Non-Radioactive Nucleic Acid Labeling Product Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Non-Radioactive Nucleic Acid Labeling Product Sales by Country (2019-2030)
3.6.3 Asia Pacific Non-Radioactive Nucleic Acid Labeling Product Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Non-Radioactive Nucleic Acid Labeling Product Market Facts & Figures by Country
3.7.1 Latin America Non-Radioactive Nucleic Acid Labeling Product Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Non-Radioactive Nucleic Acid Labeling Product Sales by Country (2019-2030)
3.7.3 Latin America Non-Radioactive Nucleic Acid Labeling Product Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Non-Radioactive Nucleic Acid Labeling Product Market Facts & Figures by Country
3.8.1 Middle East and Africa Non-Radioactive Nucleic Acid Labeling Product Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Non-Radioactive Nucleic Acid Labeling Product Sales by Country (2019-2030)
3.8.3 Middle East and Africa Non-Radioactive Nucleic Acid Labeling Product Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Non-Radioactive Nucleic Acid Labeling Product Sales by Type (2019-2030)
4.1.1 Global Non-Radioactive Nucleic Acid Labeling Product Sales by Type (2019-2024)
4.1.2 Global Non-Radioactive Nucleic Acid Labeling Product Sales by Type (2025-2030)
4.1.3 Global Non-Radioactive Nucleic Acid Labeling Product Sales Market Share by Type (2019-2030)
4.2 Global Non-Radioactive Nucleic Acid Labeling Product Revenue by Type (2019-2030)
4.2.1 Global Non-Radioactive Nucleic Acid Labeling Product Revenue by Type (2019-2024)
4.2.2 Global Non-Radioactive Nucleic Acid Labeling Product Revenue by Type (2025-2030)
4.2.3 Global Non-Radioactive Nucleic Acid Labeling Product Revenue Market Share by Type (2019-2030)
4.3 Global Non-Radioactive Nucleic Acid Labeling Product Price by Type (2019-2030)
5 Segment by Application
5.1 Global Non-Radioactive Nucleic Acid Labeling Product Sales by Application (2019-2030)
5.1.1 Global Non-Radioactive Nucleic Acid Labeling Product Sales by Application (2019-2024)
5.1.2 Global Non-Radioactive Nucleic Acid Labeling Product Sales by Application (2025-2030)
5.1.3 Global Non-Radioactive Nucleic Acid Labeling Product Sales Market Share by Application (2019-2030)
5.2 Global Non-Radioactive Nucleic Acid Labeling Product Revenue by Application (2019-2030)
5.2.1 Global Non-Radioactive Nucleic Acid Labeling Product Revenue by Application (2019-2024)
5.2.2 Global Non-Radioactive Nucleic Acid Labeling Product Revenue by Application (2025-2030)
5.2.3 Global Non-Radioactive Nucleic Acid Labeling Product Revenue Market Share by Application (2019-2030)
5.3 Global Non-Radioactive Nucleic Acid Labeling Product Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Thermo Fisher Scientific
6.1.1 Thermo Fisher Scientific Corporation Information
6.1.2 Thermo Fisher Scientific Description and Business Overview
6.1.3 Thermo Fisher Scientific Non-Radioactive Nucleic Acid Labeling Product Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Thermo Fisher Scientific Non-Radioactive Nucleic Acid Labeling Product Product Portfolio
6.1.5 Thermo Fisher Scientific Recent Developments/Updates
6.2 Roche
6.2.1 Roche Corporation Information
6.2.2 Roche Description and Business Overview
6.2.3 Roche Non-Radioactive Nucleic Acid Labeling Product Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Roche Non-Radioactive Nucleic Acid Labeling Product Product Portfolio
6.2.5 Roche Recent Developments/Updates
6.3 Promega
6.3.1 Promega Corporation Information
6.3.2 Promega Description and Business Overview
6.3.3 Promega Non-Radioactive Nucleic Acid Labeling Product Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Promega Non-Radioactive Nucleic Acid Labeling Product Product Portfolio
6.3.5 Promega Recent Developments/Updates
6.4 PerkinElmer
6.4.1 PerkinElmer Corporation Information
6.4.2 PerkinElmer Description and Business Overview
6.4.3 PerkinElmer Non-Radioactive Nucleic Acid Labeling Product Sales, Revenue and Gross Margin (2019-2024)
6.4.4 PerkinElmer Non-Radioactive Nucleic Acid Labeling Product Product Portfolio
6.4.5 PerkinElmer Recent Developments/Updates
6.5 Agilent Technologies
6.5.1 Agilent Technologies Corporation Information
6.5.2 Agilent Technologies Description and Business Overview
6.5.3 Agilent Technologies Non-Radioactive Nucleic Acid Labeling Product Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Agilent Technologies Non-Radioactive Nucleic Acid Labeling Product Product Portfolio
6.5.5 Agilent Technologies Recent Developments/Updates
6.6 General Electric
6.6.1 General Electric Corporation Information
6.6.2 General Electric Description and Business Overview
6.6.3 General Electric Non-Radioactive Nucleic Acid Labeling Product Sales, Revenue and Gross Margin (2019-2024)
6.6.4 General Electric Non-Radioactive Nucleic Acid Labeling Product Product Portfolio
6.6.5 General Electric Recent Developments/Updates
6.7 Enzo Biochem
6.6.1 Enzo Biochem Corporation Information
6.6.2 Enzo Biochem Description and Business Overview
6.6.3 Enzo Biochem Non-Radioactive Nucleic Acid Labeling Product Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Enzo Biochem Non-Radioactive Nucleic Acid Labeling Product Product Portfolio
6.7.5 Enzo Biochem Recent Developments/Updates
6.8 Merck KGaA
6.8.1 Merck KGaA Corporation Information
6.8.2 Merck KGaA Description and Business Overview
6.8.3 Merck KGaA Non-Radioactive Nucleic Acid Labeling Product Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Merck KGaA Non-Radioactive Nucleic Acid Labeling Product Product Portfolio
6.8.5 Merck KGaA Recent Developments/Updates
6.9 Vector Labs
6.9.1 Vector Labs Corporation Information
6.9.2 Vector Labs Description and Business Overview
6.9.3 Vector Labs Non-Radioactive Nucleic Acid Labeling Product Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Vector Labs Non-Radioactive Nucleic Acid Labeling Product Product Portfolio
6.9.5 Vector Labs Recent Developments/Updates
6.10 New England Biolabs
6.10.1 New England Biolabs Corporation Information
6.10.2 New England Biolabs Description and Business Overview
6.10.3 New England Biolabs Non-Radioactive Nucleic Acid Labeling Product Sales, Revenue and Gross Margin (2019-2024)
6.10.4 New England Biolabs Non-Radioactive Nucleic Acid Labeling Product Product Portfolio
6.10.5 New England Biolabs Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Non-Radioactive Nucleic Acid Labeling Product Industry Chain Analysis
7.2 Non-Radioactive Nucleic Acid Labeling Product Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Non-Radioactive Nucleic Acid Labeling Product Production Mode & Process
7.4 Non-Radioactive Nucleic Acid Labeling Product Sales and Marketing
7.4.1 Non-Radioactive Nucleic Acid Labeling Product Sales Channels
7.4.2 Non-Radioactive Nucleic Acid Labeling Product Distributors
7.5 Non-Radioactive Nucleic Acid Labeling Product Customers
8 Non-Radioactive Nucleic Acid Labeling Product Market Dynamics
8.1 Non-Radioactive Nucleic Acid Labeling Product Industry Trends
8.2 Non-Radioactive Nucleic Acid Labeling Product Market Drivers
8.3 Non-Radioactive Nucleic Acid Labeling Product Market Challenges
8.4 Non-Radioactive Nucleic Acid Labeling Product Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
